In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation
- PMID: 8997612
- DOI: 10.1016/s0014-2999(96)00734-0
In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation
Abstract
The role of the renin-angiotensin system in the haemodynamic changes induced by acute administration of N omega-nitro-L-arginine methyl ester in anaesthetised dogs was investigated. The left femoral artery and vein were cannulated for blood pressure measurement and drug administration, respectively. A Swan-Ganz catheter was introduced through the right femoral vein and advanced to the pulmonary artery. Pulmonary arterial pressure, right atrial pressure and cardiac output were also determined. N omega-Nitro-L-arginine methyl ester (0.01-10.0 mg/kg) was administered alone (control animals, n = 18) or in the presence of the angiotensin-converting enzyme inhibitors, captopril (2 mg/kg, n = 9) or enalapril (2 mg/kg, n = 7) or of the bradykinin B2 receptor antagonist D-[Arg-Hyp3, Thi5, D-Tic7, Oic8]bradykinin (Hoe 140, 0.1 mg/kg, n = 6). Cerebellum nitric oxide synthase and serum angiotensin-converting enzyme activities were also measured. N omega-Nitro-L-arginine methyl ester induced dose-dependent increases in blood pressure and systemic vascular resistance and decreases in heart rate and cardiac output. Nitric oxide synthase activity was inhibited 58% by N omega-nitro-L-arginine methyl ester (from 3.37 +/- 0.30 to 1.40 +/- 0.24 pmol/min per mg protein, P < 0.05, n = 5). Both enalapril and captopril potentiated the cardiovascular changes induced by bradykinin (300 ng/kg, bolus). Moreover, enalapril inhibited angiotensin-converting enzyme activity from 12.8 +/- 1.2 to 1.1 +/- 0.2 nmol/ml per min (P < 0.05, n = 6). Under these conditions, N omega-nitro-L-arginine methyl ester administration elicited the same haemodynamic changes as those observed in non-treated animals, except for preventing the decrease in systolic index. Hoe 140 had no effect on the cardiovascular responses to N omega-nitro-L-arginine methyl ester. These results indicate that the renin-angiotensin system does not modulate these haemodynamic changes.
Similar articles
-
Non-contribution of renin-angiotensin system to pressor response to N(G)-nitro-L-arginine in dogs.Fundam Clin Pharmacol. 2002 Feb;16(1):15-21. doi: 10.1046/j.1472-8206.2002.00065.x. Fundam Clin Pharmacol. 2002. PMID: 11903508
-
Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism.Cardiovasc Res. 1994 Feb;28(2):209-14. doi: 10.1093/cvr/28.2.209. Cardiovasc Res. 1994. PMID: 8143302
-
Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.Eur J Pharmacol. 2005 Jun 15;516(3):253-9. doi: 10.1016/j.ejphar.2005.04.004. Eur J Pharmacol. 2005. PMID: 15963975
-
Nitric oxide inhibition and renal alterations.J Cardiovasc Pharmacol. 2001 Nov;38 Suppl 2:S65-70. doi: 10.1097/00005344-200111002-00016. J Cardiovasc Pharmacol. 2001. PMID: 11811381 Review.
-
Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis.Mol Cell Biochem. 1995 Jun 7-21;147(1-2):89-97. doi: 10.1007/BF00944788. Mol Cell Biochem. 1995. PMID: 7494560 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources